Please Wait...

ClearSite RBM

Bioclinica helps companies achieve ICH E6 compliance as well as the promise of risk-based monitoring through a modern, cloud-based solution. Our unique clinical trial quality management software allows you to deploy a risk-based, quality-management approach across studies, which easily leverages existing trial data, systems, and processes to predict and correct risk throughout the trial lifecycle – delivering improved patient safety and data quality.

How Does Bioclinica Empower Risk-Based Monitoring?

Patient Focus

Built for the Job

Start with a comprehensive, clinical trial quality management software application purpose-built for designing, deploying, and managing Risk-Based Monitoring (RBM) trials.

Maintain Control

Bioclinica Risk-Based Monitoring helps you oversee data quality and maintain control of trials even when outsourcing to multiple CROs.

See your Data, and use it!

Leverage advanced visualizations, analytics, and machine learning for robust, holistic risk prediction, detection, analysis, and management. Our technology is designed to fit into existing R&D ecosystems with no new software/hardware requirements.

Works with Multiple Data Sources

With a source data agnostic, API enabled solution you can seamlessly exchange data for use as a companion product. Integration is underway with all Bioclinica products.

Leverage Bioclinica's Expertise

What effect does ICH E6 R2 have on risk-based monitoring and overall clinical trial quality risk management?

CONTACT US DOWNLOAD WHITE PAPER

Business Challenges

Sponsors

  • Reactive, non-risk-based approach
  • Manually driven processes using disconnected systems
  • Demonstrate quality oversight was achieved
  • Standardized approach to vendor oversight
  • Understanding quality in a multi-vendor model
  • Ensuring control over outsourced activities
  • Reactive vs. proactive
  • Data-driven decision making
  • ICH E6 R2
  • Inspection readiness

CROs

  • Market differentiation via technology
  • Pricing and margin pressures
  • Regulatory compliance
  • Site quality
  • Lack of transparency

  • Reactive vs. proactive
  • Data-driven decision making
  • ICH E6 R2
  • Inspection readiness

Traditional Attempts to Address Challenges

Excel Spreadsheets

Multiple Tools / Applications

In-House Built Systems

Pushing the Burden to CRAs

Outsourcing to CROs

Benefits of ClearSite

Bioclinica helps you take a quality management approach to trial execution, inclusive of risk-based monitoring. We help you detect and track identified risks using Key Risk Indicators (KRIs), as well as risks you may not be aware of through advanced machine learning and predictive analytic capabilities. Whether you are transitioning to a risk-based approach or are experienced with risk-based monitoring, Bioclinica can support your needs and help deliver:

  • Improved operational efficiency
  • Risk mitigation
  • Regulatory compliance

DOWNLOAD INFOGRAPHIC

Benefits of ClearSite

ADDITIONAL RESOURCES

RBM Professional Services Offerings

Download Overview Sheet

What Effect Does ICH E6 R2 Have on Risk-Based Monitoring and Overall Quality Risk Management?

Download White Paper

Running Better Trials Taking an Intelligent Monitoring Approach

Download White Paper

Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Handy guide for the pharmacovigilance folks! https://t.co/tOyQWkiNhW
bioclinica (Yesterday)
#ClinicalResearch sites, REJOICE @bioclinica SMART Submit 4 cloud rsch image mgmt /subm is here! @OutsourcPharmahttp://ow.ly/odCh30grhnY
bioclinica (Yesterday)
What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (2 days ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (3 days ago)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (3 days ago)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (3 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices